-
1
-
-
30844433590
-
The Impact of Obesity on Rising Medical Care Spending
-
Thorpe KE, Florence CS, Howard DH, Joski P: The Impact of Obesity on Rising Medical Care Spending. Health Aff (Millwood) 2004, W4:480-486.
-
(2004)
Health Aff (Millwood)
, vol.W4
, pp. 480-486
-
-
Thorpe, K.E.1
Florence, C.S.2
Howard, D.H.3
Joski, P.4
-
3
-
-
84971226544
-
National Diabetes Fact Sheet
-
American Diabetes Association
-
American Diabetes Association: 2011 National Diabetes Fact Sheet. 2011. http://www.diabetes.org/diabetes-basics/diabetes-statistics/?loc= DropDownDB-stats.
-
(2011)
2011
-
-
-
5
-
-
43049125182
-
The Financial Burden of Overweight and Obesity among Elderly Americans: The Dynamics of Weight, Longevity, and Health Care Cost
-
Yang Z, Hall AG: The Financial Burden of Overweight and Obesity among Elderly Americans: The Dynamics of Weight, Longevity, and Health Care Cost. Health Serv Res 2008, 43(3):849-868.
-
(2008)
Health Serv Res
, vol.43
, Issue.3
, pp. 849-868
-
-
Yang, Z.1
Hall, A.G.2
-
7
-
-
70449517253
-
Diabetes Prevention Program Research Group: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
-
Diabetes Prevention Program Research Group: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686.
-
(2009)
Lancet
, vol.374
, pp. 1677-1686
-
-
-
8
-
-
84856388467
-
Two year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study
-
Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH: Two year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 2012, 95(2):297-308.
-
(2012)
Am J Clin Nutr
, vol.95
, Issue.2
, pp. 297-308
-
-
Garvey, W.T.1
Ryan, D.H.2
Look, M.3
Gadde, K.M.4
Allison, D.B.5
Peterson, C.A.6
Schwiers, M.7
Day, W.W.8
Bowden, C.H.9
-
9
-
-
80054955347
-
Long-Term Persistence of Hormonal Adaptations to Weight Loss
-
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J: Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med 2011, 365:1597-1604.
-
(2011)
N Engl J Med
, vol.365
, pp. 1597-1604
-
-
Sumithran, P.1
Prendergast, L.A.2
Delbridge, E.3
Purcell, K.4
Shulkes, A.5
Kriketos, A.6
Proietto, J.7
-
10
-
-
77954635020
-
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
-
Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanhan WR: Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management. N Engl J Med 2010, 363:245-256.
-
(2010)
N Engl J Med
, vol.363
, pp. 245-256
-
-
Smith, S.R.1
Weissman, N.J.2
Anderson, C.M.3
Sanchez, M.4
Chuang, E.5
Stubbe, S.6
Bays, H.7
Shanhan, W.R.8
-
11
-
-
84971209269
-
-
Belviq full prescribing information
-
Belviq full prescribing information. 2012. http://us.eisai.com/package_inserts/BelviqPI.pdf.
-
(2012)
-
-
-
12
-
-
77956057548
-
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
-
Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dynayevich E: Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2010, 376:595-605.
-
(2010)
Lancet
, vol.376
, pp. 595-605
-
-
Greenway, F.L.1
Fujioka, K.2
Plodkowski, R.A.3
Mudaliar, S.4
Guttadauria, M.5
Erickson, J.6
Kim, D.D.7
Dynayevich, E.8
-
13
-
-
84971356519
-
-
Contrave FDA Advisory Committee Briefing Document (NDA 200063)
-
Contrave FDA Advisory Committee Briefing Document (NDA 200063). 2010. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM235672.pdf+Contrave&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&ie=UTF-8&access=p&oe=UTF-8.
-
(2010)
-
-
-
14
-
-
79954561234
-
Effects of low-dose controlled-release phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): A randomized, placebo-controlled, phase 3 trial
-
Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW: Effects of low-dose controlled-release phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomized, placebo-controlled, phase 3 trial. Lancet 2011, 377:1341-1352.
-
(2011)
Lancet
, vol.377
, pp. 1341-1352
-
-
Gadde, K.M.1
Allison, D.B.2
Ryan, D.H.3
Peterson, C.A.4
Troupin, B.5
Schwiers, M.L.6
Day, W.W.7
-
15
-
-
84856246606
-
Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP)
-
Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW: Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) 2012, 20(2):330-342.
-
(2012)
Obesity (Silver Spring)
, vol.20
, Issue.2
, pp. 330-342
-
-
Allison, D.B.1
Gadde, K.M.2
Garvey, W.T.3
Peterson, C.A.4
Schwiers, M.L.5
Najarian, T.6
Tam, P.Y.7
Troupin, B.8
Day, W.W.9
-
16
-
-
84971290570
-
How Obesity Threatens America's Future
-
Fas in Fat
-
Fas in Fat: How Obesity Threatens America's Future. Trust for America's Health; 2011. http://www.rwjf.org/content/dam/web-assets/2011/07/f-as-in-fat.
-
(2011)
Trust For America's Health
-
-
|